{"id":"https://openalex.org/W2083786790","doi":"https://doi.org/10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","title":"Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2 /neu-positive breast cancer cells","display_name":"Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2 /neu-positive breast cancer cells","publication_year":2001,"publication_date":"2001-10-01","ids":{"openalex":"https://openalex.org/W2083786790","doi":"https://doi.org/10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","mag":"2083786790","pmid":"https://pubmed.ncbi.nlm.nih.gov/11592078"},"language":"en","primary_location":{"id":"doi:10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","doi":"https://doi.org/10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1521-4141%282001010%2931%3A10%3C3016%3A%3AAID-IMMU3016%3E3.0.CO%3B2-J","source":{"id":"https://openalex.org/S126191069","display_name":"European Journal of Immunology","issn_l":"0014-2980","issn":["0014-2980","1521-4141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1521-4141%282001010%2931%3A10%3C3016%3A%3AAID-IMMU3016%3E3.0.CO%3B2-J","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060897770","display_name":"William Edgar Carson","orcid":"https://orcid.org/0000-0001-7024-7533","observed_orcids":["https://orcid.org/0000-0001-7024-7533"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William E. Carson","raw_affiliation_strings":["Department of Surgery, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus 43210, USA. carson-1@medctr.osu.edu","Department of Molecular Virology, Immunology and Medical Genetics, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA","Department of Surgery, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus 43210, USA. carson-1@medctr.osu.edu","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]},{"raw_affiliation_string":"Department of Molecular Virology, Immunology and Medical Genetics, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]},{"raw_affiliation_string":"Department of Surgery, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008768048","display_name":"Robin Parihar","orcid":"https://orcid.org/0000-0002-3283-6713","observed_orcids":["https://orcid.org/0000-0002-3283-6713"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Parihar","raw_affiliation_strings":["Department of Molecular Virology, Immunology and Medical Genetics, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Virology, Immunology and Medical Genetics, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114039580","display_name":"Matthew J. Lindemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J. Lindemann","raw_affiliation_strings":["Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059373658","display_name":"Nicola Personeni","orcid":"https://orcid.org/0000-0002-7995-272X","observed_orcids":["https://orcid.org/0000-0002-7995-272X"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicola Personeni","raw_affiliation_strings":["Department of Medicine, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027100101","display_name":"Julie E. Dierksheide","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Dierksheide","raw_affiliation_strings":["Department of Pathology, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106085904","display_name":"Neal J. Meropol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal J. Meropol","raw_affiliation_strings":["Division of Medical Science, Fox Chase Cancer Center, Philadelphia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Science, Fox Chase Cancer Center, Philadelphia, USA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose Baselga","raw_affiliation_strings":["Medical Oncology Service, Hospital Universitari Vall D' Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Service, Hospital Universitari Vall D' Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049192022","display_name":"Michael A. Caligiuri","orcid":"https://orcid.org/0000-0002-4095-3020","observed_orcids":["https://orcid.org/0000-0002-4095-3020"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Caligiuri","raw_affiliation_strings":["Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA","Department of Molecular Virology, Immunology and Medical Genetics, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]},{"raw_affiliation_string":"Department of Molecular Virology, Immunology and Medical Genetics, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, USA","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5060897770"],"corresponding_institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"],"apc_list":{"value":4550,"currency":"USD","value_usd":4550},"apc_paid":{"value":4550,"currency":"USD","value_usd":4550},"fwci":1.7777,"has_fulltext":true,"cited_by_count":154,"citation_normalized_percentile":{"value":0.84473535,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"31","issue":"10","first_page":"3016","last_page":"3025"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.968999981880188},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9929999709129333},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.890999972820282},{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.9049999713897705},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8159999847412109},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9779999852180481},{"id":"https://openalex.org/keywords/fc-gamma-receptor","display_name":"Fc gamma receptor","score":0.6470000147819519},{"id":"https://openalex.org/keywords/low-dose-il-2-therapy","display_name":"low-dose IL-2 therapy","score":0.6740000247955322},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7590000033378601},{"id":"https://openalex.org/keywords/cd25","display_name":"CD25","score":0.7149999737739563},{"id":"https://openalex.org/keywords/cd69","display_name":"CD69","score":0.9869999885559082},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.7509999871253967},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.8671908378601074},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.63512122631073},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6139861345291138},{"id":"https://openalex.org/C149532602","wikidata":"https://www.wikidata.org/wiki/Q2409681","display_name":"Interleukin 12","level":4,"score":0.6014886498451233},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5690555572509766},{"id":"https://openalex.org/C2781462264","wikidata":"https://www.wikidata.org/wiki/Q78482053","display_name":"CD16","level":5,"score":0.5597979426383972},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5169036388397217},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5155208110809326},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5146797299385071},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4741758108139038},{"id":"https://openalex.org/C2778102761","wikidata":"https://www.wikidata.org/wiki/Q332181","display_name":"Natural killer cell","level":4,"score":0.47134870290756226},{"id":"https://openalex.org/C28651165","wikidata":"https://www.wikidata.org/wiki/Q4259786","display_name":"Lymphokine-activated killer cell","level":5,"score":0.46471914649009705},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.4600526988506317},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.4266134202480316},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3900231122970581},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.2551337480545044},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2467135488986969},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23489806056022644},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.21484294533729553},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.16892129182815552},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10758852958679199},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.08785095810890198},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.05989214777946472},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D017452","descriptor_name":"Receptors, IgG","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D019002","descriptor_name":"CD56 Antigen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","doi":"https://doi.org/10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1521-4141%282001010%2931%3A10%3C3016%3A%3AAID-IMMU3016%3E3.0.CO%3B2-J","source":{"id":"https://openalex.org/S126191069","display_name":"European Journal of Immunology","issn_l":"0014-2980","issn":["0014-2980","1521-4141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:11592078","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11592078","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of immunology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","doi":"https://doi.org/10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1521-4141%282001010%2931%3A10%3C3016%3A%3AAID-IMMU3016%3E3.0.CO%3B2-J","source":{"id":"https://openalex.org/S126191069","display_name":"European Journal of Immunology","issn_l":"0014-2980","issn":["0014-2980","1521-4141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G376373994","display_name":null,"funder_award_id":"CA 68458","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4151404497","display_name":"IL15 AND NATURAL KILLER (NK) CELL FUNCTION","funder_award_id":"K11CA068326","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000887552","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016058","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2083786790.pdf","grobid_xml":"https://content.openalex.org/works/W2083786790.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W13154270","https://openalex.org/W159704211","https://openalex.org/W1499509353","https://openalex.org/W1557111800","https://openalex.org/W1656008630","https://openalex.org/W1965219484","https://openalex.org/W1966887368","https://openalex.org/W1973284702","https://openalex.org/W1977299595","https://openalex.org/W1990135376","https://openalex.org/W1993555313","https://openalex.org/W1998870570","https://openalex.org/W2006073656","https://openalex.org/W2006174096","https://openalex.org/W2011470870","https://openalex.org/W2028345258","https://openalex.org/W2028743952","https://openalex.org/W2039609199","https://openalex.org/W2071763005","https://openalex.org/W2077252019","https://openalex.org/W2082117763","https://openalex.org/W2090639012","https://openalex.org/W2095156669","https://openalex.org/W2095636772","https://openalex.org/W2103827956","https://openalex.org/W2104066024","https://openalex.org/W2112475887","https://openalex.org/W2128402413","https://openalex.org/W2132363654","https://openalex.org/W2149235787","https://openalex.org/W2161428561","https://openalex.org/W2264655007","https://openalex.org/W2314331148","https://openalex.org/W2407291496"],"related_works":["https://openalex.org/W2039609199","https://openalex.org/W2048772193","https://openalex.org/W2588820636","https://openalex.org/W6992992757","https://openalex.org/W2766024102","https://openalex.org/W4313389567","https://openalex.org/W2412257809","https://openalex.org/W2341135212","https://openalex.org/W1788305820","https://openalex.org/W6983799442"],"abstract_inverted_index":{"The":[0],"Her2/neu":[1,286],"(c-erbB-2)":[2],"oncogene":[3],"encodes":[4],"a":[5,22,50,101,206],"185-kDa":[6],"protein":[7],"tyrosine":[8],"kinase":[9],"which":[10],"is":[11,19],"overexpressed":[12],"in":[13,63,100,106,184,233,244,279],"20%":[14],"of":[15,37,49,69,83,111,124,162,190,201,211,225,247,253,258,273],"breast":[16,96],"adenocarcinomas":[17],"and":[18,73,93,127,137,263,276],"recognized":[20],"by":[21,131,168,240],"humanized":[23],"anti-Her2/neu":[24],"monoclonal":[25],"antibody":[26,180,232],"(mAb)":[27],"(rhu4D5":[28],"or":[29,56,109,158],"Herceptin).":[30],"Natural":[31],"killer":[32],"(NK)":[33],"cells":[34,59,89,130,134,165,173,193,199,203,213,238,243],"are":[35],"capable":[36],"mediating":[38],"antibody-dependent":[39],"cell":[40,98],"cytotoxicity":[41,104,186],"(ADCC)":[42],"against":[43,90],"antibody-coated":[44],"targets":[45,149],"via":[46,66],"their":[47],"expression":[48],"low-affinity":[51],"receptor":[52,179],"for":[53,230],"IgG":[54],"(FcgammaRIII":[55],"CD16).":[57],"NK":[58,88,133,172,212,237],"can":[60],"be":[61],"expanded":[62],"cancer":[64,97],"patients":[65,222,280],"the":[67,107,154,185,197,234,245,270,285],"administration":[68],"low-dose":[70,218],"interleukin-2":[71],"(IL-2)":[72],"become":[74],"potent":[75],"cytotoxic":[76],"effectors":[77],"following":[78],"exposure":[79],"to":[80,182,215,269],"high":[81],"doses":[82],"IL-2.":[84,219],"We":[85],"tested":[86],"IL-2-activated":[87,132],"Her2/neu+":[91],"(MCF-7Her2/neu)":[92],"Her2/neu-":[94],"(MDA-468)":[95],"lines":[99],"4-h":[102],"51Cr-release":[103],"assay":[105],"presence":[108,246],"absence":[110],"rhu4D5":[112,226,274],"mAb":[113,157,227,275],"(effector":[114],":":[115,120],"target":[116,129,192],"ratio":[117],"=":[118],"10":[119],"1).":[121],"Specific":[122],"lysis":[123],"rhu4D5-coated":[125,163,241],"MCF-7Her2/neu":[126,164,191],"MDA-468":[128],"was":[135,144,166,194],"35%":[136],"3%,":[138],"respectively":[139],"(p":[140],"<":[141],"0.05).":[142],"Lysis":[143,161],"less":[145],"than":[146],"5%":[147],"when":[148,171,196],"were":[150,174],"treated":[151],"with":[152,176,217,255,281],"either":[153],"non-humanized":[155],"mu4D5":[156],"control":[159],"huIgG.":[160],"inhibited":[167],"80":[169],"%":[170],"pre-treated":[175],"an":[177],"anti-Fc":[178],"prior":[181],"use":[183,272],"assay.":[187,236],"Enhanced":[188],"ADCC":[189,235],"seen":[195],"effector":[198],"consisted":[200],"mononuclear":[202],"obtained":[204],"from":[205,221],"patient":[207],"demonstrating":[208],"significant":[209],"expansion":[210],"secondary":[214],"therapy":[216,278],"Serum":[220],"receiving":[223],"infusions":[224],"could":[228],"substitute":[229],"exogenous":[231],"activated":[239],"tumor":[242],"IL-2":[248,277],"also":[249],"produced":[250],"large":[251],"amounts":[252],"IFN-gamma":[254],"concomitant":[256],"up-regulation":[257],"cell-surface":[259],"activation":[260],"markers":[261],"CD25":[262],"CD69.":[264],"These":[265],"results":[266],"lend":[267],"support":[268],"concurrent":[271],"cancers":[282],"that":[283],"express":[284],"oncogene.":[287]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}